{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-068813","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.646680+00:00","generated_at":"2026-05-16T00:19:12.916562+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Decoy Therapeutics shareholders approve 2026 equity plan and reverse stock split","bullets":["Approved 2026 Equity Incentive Plan: 351,837 for, 68,978 against, 55,703 abstentions.","Approved reverse stock split of common stock at ratio between 1:4 and 1:15, at board's discretion.","Reverse split proposal: 2,187,125 votes for, 507,474 against, 2,173 abstentions.","Adjournment proposal was unnecessary due to sufficient votes; broker non-votes totaled 2,220,254."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-068813","json":"https://secwatch.observer/filing/0001193125-26-068813.json","markdown":"https://secwatch.observer/filing/0001193125-26-068813.md","text":"https://secwatch.observer/filing/0001193125-26-068813.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526068813/0001193125-26-068813-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526068813/dcoy-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:19:12.916562+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}